Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
about
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesChimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.Modulation of 5' splice site selection using tailed oligonucleotides carrying splicing signals.SAM68: Signal Transduction and RNA Metabolism in Human CancerLong non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosisIsolation of XAB2 complex involved in pre-mRNA splicing, transcription, and transcription-coupled repair.TAF6delta controls apoptosis and gene expression in the absence of p53.Determining the impact of alternative splicing events on transcriptome dynamics.TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53.A molecular inversion probe assay for detecting alternative splicingCorrection of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.Engineering splicing factors with designed specificitiesRNA therapeutics: beyond RNA interference and antisense oligonucleotides.Anti-tumor activity of splice-switching oligonucleotides.Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.Splicing predictions reliably classify different types of alternative splicing.Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.A G-tract element in apoptotic agents-induced alternative splicing.RNA sequencing of cancer reveals novel splicing alterations.Modulating the expression of disease genes with RNA-based therapy.A nucleus-targeted alternately spliced Nix/Bnip3L protein isoform modifies nuclear factor κB (NFκB)-mediated cardiac transcription.Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNAModification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells.Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells.AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesAlternative splicing programs in prostate cancer.Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3' splice site pairing.Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.Modulation of RNA splicing as a potential treatment for cancer.Temperature-dependent splicing of beta-globin pre-mRNA.
P2860
Q24645148-46E9204D-EFC5-4F64-97B0-2E7172BC249CQ24811283-563140D1-FFE6-48FD-966D-CFDF67B68AF9Q25255627-F2425E44-2BF8-416C-AB4F-C5F24DC2C874Q26798149-F8B07EC0-70D3-4E2F-A0B9-87683156699AQ28243266-A95DB607-0596-48CF-86FE-3032F1F88920Q33304951-48BB7172-BA1F-427F-A4E6-7658F3B14B09Q33351996-01D22781-8665-4D72-B8D3-23025DDD762DQ33379266-4030118A-B68B-4BA3-8649-57FD327A912EQ33526062-9FC23C73-5501-48F7-98AC-886C1EEBE3A1Q33774698-F2ECA91A-EDF9-4A0C-A915-F517E971E663Q33980928-8252F719-313D-45D5-8E73-B70A03C8C63FQ34002454-9AE9FD09-97BB-48F2-BB71-DA055386562BQ34027064-4B046882-243A-4B82-9192-5DC5E1B8BAF8Q34157516-34A52F4B-A245-4AB6-B0DB-8059D9223643Q34235465-5208D762-125F-4013-B6B1-92D4463B6824Q34248493-EDFD447B-27CE-43E2-B16C-574483D26DA9Q34401490-7BD3DFDC-ADEF-4DFF-84B5-C9675549A089Q35202466-050FD0A7-FE58-4415-AC74-4BE7651CEF43Q35534944-5DF7D556-918C-4ADE-8C2A-22E86483B8DFQ35536316-6B83D579-85D6-45B8-AC6B-DF6C7D316293Q35699768-35A76AB9-E47C-4E52-90E7-342991050EEFQ35740083-367DDAD6-3F3F-4DD2-BA14-97776A4BBA8CQ35805025-158D1EB2-356E-42E7-A154-4F4628CFFF51Q35973562-04044480-BE73-4935-AE34-905AFA31783CQ36351445-F0B0D16A-90FF-4A27-BABD-D87AC9952B09Q36715591-C1BA1E34-5EE9-4424-A72B-98C0AD11F08EQ36782437-36B0647B-114E-4320-92D5-81EE81F017B8Q36866549-44773EF4-3BA8-4BF5-954C-25D1B0B19F5CQ36890525-5759F3E0-1E8D-401F-820B-C0560CEB921AQ37068616-B3DF20FE-EB87-4604-AA35-F1473FA89554Q37165342-2B1620B1-5E37-4F1B-BE32-5FF50577B70CQ37192466-1DD0044C-559D-4BAF-B733-162FC840FD20Q37425226-13859C8E-4CCB-4B74-9F8C-DFD26B82F664Q37819299-A5F4ABAE-DD37-467D-9847-21B44A675529Q38132132-E8F1B0CE-9B45-4C66-8D21-7535D2C3F087Q38296244-063F6EE3-59DF-4ADC-BB5D-ACB303A3AFC7Q38349730-AFB5AB72-C560-4D5B-BB07-E891FE17E88DQ38361912-22F00127-103B-49AF-8B25-9BBB345E7D09Q39427653-D7941360-807F-4817-94A5-6755B8DE4AABQ39682226-4249461A-5306-4399-B894-7E91DB2C5B39
P2860
Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Modification of alternative sp ...... s of apoptosis and cell death.
@en
Modification of alternative sp ...... s of apoptosis and cell death.
@nl
type
label
Modification of alternative sp ...... s of apoptosis and cell death.
@en
Modification of alternative sp ...... s of apoptosis and cell death.
@nl
prefLabel
Modification of alternative sp ...... s of apoptosis and cell death.
@en
Modification of alternative sp ...... s of apoptosis and cell death.
@nl
P2093
P356
P1476
Modification of alternative sp ...... is of apoptosis and cell death
@en
P2093
P304
16411-16417
P356
10.1074/JBC.M009256200
P407
P577
2001-02-07T00:00:00Z